Health Topics A-Z

  1. Home
  2. Health
  3. Health Topics A-Z

From About.com

About.com Health's Disease and Condition content is reviewed by our Medical Review Board

ENCYCLOPEDIA INDEX
Injury Disease Nutrition Poison Symptoms Surgery Test Special Topic
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pagets disease

Overview Symptoms Treatment Prevention
Alternative Names:
Osteitis deformans
Treatment:

Drug therapy is aimed at suppressing bone breakdown. Currently, there are several classes of medications that inhibit bone resorption that are used in the treatment of Paget's disease. These include: bisphosphonates, calcitonin, and plicamycin.

The biphosphonates are the first-line treatment and include the following medications: etidronate (Didronel), alendronate (Fosamax), pamidronate (Aredia), tiludronate (Skelid), and risedronate (Actonel). The Calcitonin class includes intranasal (Miacalcin) and subcutaneous (Calcimar) forms. Plicamycin (Mitrhracin) may also be prescribed. Analgesics or nonsteroidal anti-inflammatory medications (NSAIDS) may be given for pain.

Localized Paget's disease requires no treatment, if there are no symptoms and no evidence of active disease. Orthopedic surgery may be required to correct a specific deformity in severe cases.

Support Groups:

Paget Foundation
120 Wall St., Suite 1602
New York, NY 10005-4001
Toll-free: 800-23-PAGET
Ph: 212-509-5335
Website: http://www.paget.org
E-mail: PagetFdn@aol.com

Expectations (prognosis):
Disease activity and symptoms can generally be controlled with current medications. Malignant changes of bone occur in less than 1% of people affected.
Complications:
  • Deafness
  • Spinal stenosis
  • Deformities
  • Bone fractures
  • Paraplegia
  • Cardiac failure
Calling your health care provider:

Call for an appointment with your health care provider if symptoms of Paget's disease develop.

X-ray
X-ray
adam.com

Explore Health Topics A-Z

About.com Special Features

Health Topics A-Z

  1. Home
  2. Health
  3. Health Topics A-Z

©2009 About.com, a part of The New York Times Company.

All rights reserved.